Please use this identifier to cite or link to this item:
Title: GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation
Authors: MORAES-VIEIRA, Pedro Manoel M.TAKENAKA, Maisa C. S.SILVA, Hernandez M.MONTEIRO, Sandra MariaAGENA, FabianaLEMOS, FrancineSAITOVITCH, DavidKALIL, JorgeCOELHO, Veronica
Citation: CLINICAL IMMUNOLOGY, v.142, n.2, p.117-126, 2012
Abstract: Some organ-transplanted patients achieve a state of ""operational tolerance"" (01) in which graft function is maintained after the complete withdrawal of immunosuppressive drugs. We used a gene panel of regulatory/inflammatory molecules (FOXP3, GATA3, 100, TGFB1, TGFBR1/TBX21, TNF and IFNG) to investigate the gene expression profile in peripheral blood mononuclear cells of renal-transplanted individuals experiencing OT compared to transplanted individuals not displaying OT and healthy individuals (HI). OT subjects showed a predominant regulatory (REG) profile with higher gene expression of GATA3, FOXP3, TGFB1 and TGFB receptor 1 compared to the other groups. This predominant REG gene expression profile displayed stability over time. The significant GATA3 gene and protein expressions in OT individuals suggest that a Th2 deviation may be a relevant pathway to OT. Moreover, the capacity of the REG/INFLAMMA gene panel to discriminate OT by peripheral blood analysis indicates that this state has systemic repercussions.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/19
LIM/19 - Laboratório de Histocompatibilidade e Imunidade Celular

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)820.86 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.